The antioxidants neopterin/7,8‐dihydroneopterin: Novel biomarker and muscle protectant in Duchenne muscular dystrophy
- 28 June 2018
- journal article
- editorial
- Published by Wiley in Experimental Physiology
- Vol. 103 (7) , 939-940
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Neopterin/7,8‐dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle functionExperimental Physiology, 2018
- Pre‐clinical evaluation of N‐acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophyThe Journal of Physiology, 2017
- Antioxidants, inflammation and cardiovascular diseaseWorld Journal of Cardiology, 2014
- Biomarkers of inflammatory and auto-immune central nervous system disordersCurrent Opinion in Pediatrics, 2010
- Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8‐dihydroneopterin synthesisBritish Journal of Pharmacology, 2008
- X chromosome-linked muscular dystrophy (mdx) in the mouse.Proceedings of the National Academy of Sciences of the United States of America, 1984